SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001651308-21-000032
Filing Date
2021-02-17
Accepted
2021-02-17 16:10:00
Documents
15
Period of Report
2021-02-17
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bgne-20210217.htm   iXBRL 8-K 42827
2 EX-99.1 a8-kex991x2x17x2021.htm EX-99.1 31206
  Complete submission text file 0001651308-21-000032.txt   232841

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bgne-20210217.xsd EX-101.SCH 2505
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bgne-20210217_cal.xml EX-101.CAL 793
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bgne-20210217_def.xml EX-101.DEF 1757
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bgne-20210217_lab.xml EX-101.LAB 25214
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bgne-20210217_pre.xml EX-101.PRE 13249
8 EXTRACTED XBRL INSTANCE DOCUMENT bgne-20210217_htm.xml XML 12165
Mailing Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108
Business Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108 13459494123
BeiGene, Ltd. (Filer) CIK: 0001651308 (see all company filings)

IRS No.: 981209416 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37686 | Film No.: 21644826
SIC: 2834 Pharmaceutical Preparations